Cargando…

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu

Detalles Bibliográficos
Autores principales:	Nechaeva, Elena A, Bogryantseva, Marina P, Ryzhikov, Alexander B, P'yankova, Ol'ga G, Sen'kina, Tatyana Y, F Radaeva, Irina, Nechaev, Sergey Y, Ryndyuk, Natalya I, Kuzubov, Vladimir I, Gin'ko, Zoya I, Kiseleva, Irina V, Rudenko, Larisa G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685333/ http://dx.doi.org/10.1186/1753-6561-9-S9-P73

Ejemplares similares

Development of live cultural pandemic influenza vaccine Vector-Flu
por: Nechaeva, Elena A, et al.
Publicado: (2011)

Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza
por: Kiseleva, Irina, et al.
Publicado: (2017)

COVID-19 Shuts Doors to Flu but Keeps Them Open to Rhinoviruses
por: Kiseleva, Irina, et al.
Publicado: (2021)

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories
por: Rudenko, Larisa, et al.
Publicado: (2016)

Phenotypic characteristics of novel swine‐origin influenza A/California/07/2009 (H1N1) virus
por: Kiseleva, Irina, et al.
Publicado: (2009)

Contribution of Neuraminidase of Influenza Viruses to the Sensitivity to Sera Inhibitors and Reassortment Efficiency
por: Kiseleva, Irina, et al.
Publicado: (2014)

COVID-19 in Light of Seasonal Respiratory Infections
por: Kiseleva, Irina, et al.
Publicado: (2020)

PP-180 Elaboration of viral vaccine delivery
por: Nechaeva, Elena, et al.
Publicado: (2009)

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
por: Rekstin, Andrey, et al.
Publicado: (2014)

Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses
por: Al Farroukh, Mohammad, et al.
Publicado: (2022)

Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research
por: Kiseleva, Irina, et al.
Publicado: (2020)

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses
por: Shcherbik, Svetlana, et al.
Publicado: (2015)

A promising inactivated whole-virion SARS-CoV-2 vaccine
por: Isakova-Sivak, Irina, et al.
Publicado: (2021)

M2e-based universal influenza vaccines: a historical overview and new approaches to development
por: Mezhenskaya, Daria, et al.
Publicado: (2019)

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
por: Kiseleva, Irina, et al.
Publicado: (2018)

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
por: Isakova-Sivak, Irina, et al.
Publicado: (2019)

Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus
por: Stepanova, Ekaterina, et al.
Publicado: (2020)

Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine
por: Matyushenko, Victoria, et al.
Publicado: (2017)

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A., et al.
Publicado: (2016)

Coating the Flu with Sticky Polymers to Look for New Drugs
por: Gibson, Matthew I.
Publicado: (2016)

From SARS and avian flu to swine flu
por: Wong, G.W.K.
Publicado: (2010)

Impacts of rapid flu clinic services at an emergency department during the pandemic flu season
por: Shih, Hsin-I., et al.
Publicado: (2012)

Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
por: Rudenko, Larisa, et al.
Publicado: (2018)

Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests
por: Rak, Alexandra, et al.
Publicado: (2022)

New Points of Departure for More Global Influenza Vaccine Use
por: Kiseleva, Irina
Publicado: (2020)

Current Opinion in LAIV: A Matter of Parent Virus Choice
por: Kiseleva, Irina
Publicado: (2022)

Suitability of Root and Rhizome Anatomy for Taxonomic Classification and Reconstruction of Phylogenetic Relationships in the Tribes Cardueae and Cichorieae (Asteraceae)
por: Ginko, Elisabeth, et al.
Publicado: (2016)

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells
por: Shcherbik, Svetlana, et al.
Publicado: (2019)

Flu Days
por: Makuck, Peter
Publicado: (2016)

The “Flu” Poem
por: Anonymus,
Publicado: (1919)

Early Events in Actin Cytoskeleton Dynamics and E-Cadherin-Mediated Cell-Cell Adhesion during Epithelial-Mesenchymal Transition
por: Zhitnyak, Irina Y., et al.
Publicado: (2020)

Characterization and Genome Analysis of the First Facultatively Alkaliphilic Thermodesulfovibrio Isolated from the Deep Terrestrial Subsurface
por: Frank, Yulia A., et al.
Publicado: (2016)

FluBreaks: Early Epidemic Detection from Google Flu Trends
por: Pervaiz, Fahad, et al.
Publicado: (2012)

Anti-Influenza Effect of Nanosilver in a Mouse Model
por: Kiseleva, Irina V., et al.
Publicado: (2020)

In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19
por: Kudryavtsev, Igor, et al.
Publicado: (2022)

Bird flu vaccine.
Publicado: (1998)

The relentless flu drug.
Publicado: (1998)

A case of the flu
por: Petsko, Gregory A
Publicado: (2012)

2012 Pandemic Flu
por: Ghio, F E, et al.
Publicado: (2012)

Flu and pulmonary fibrosis
por: Sharma, Bharat Bhushan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mfkrl3npmb1tqihrqcsq2eonmp